Selena R Magalotti1, Mandy Neudecker1, Solomon G Zaraa1, Molly K McVoy2,3,4. 1. Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. 2. Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. molly.mcvoy@uhhospitals.org. 3. Case Western University School of Medicine, Cleveland, OH, USA. molly.mcvoy@uhhospitals.org. 4. W. O. Walker Building, Division of Child and Adolescent Psychiatry, 10524 Euclid Ave, Suite 1155A, Cleveland, OH, USA. molly.mcvoy@uhhospitals.org.
Abstract
PURPOSE OF REVIEW: Youth aggression is common and has a significant burden on individuals, families, and society. However, its treatment is often a challenge for clinicians. Thus, this review will examine the current understanding of youth aggression, conceptualize aggression as a symptom rather than its own disorder, and provide an overview of treatment strategies. RECENT FINDINGS: Youth aggression is associated with complex genetic, neurobiological, and environmental risks. Prevention strategies are of the utmost importance for at-risk families and youth. Psychosocial interventions are the first line treatment. But if not fully effective, then pharmacologic interventions-including psychostimulants, alpha-2 agonists, atomoxetine, and risperidone-have shown benefits. Other medications, such as SSRIs, can be useful in certain scenarios. It is important to conceptualize youth aggression as being a trans-diagnostic symptom in psychopathology. Determining the underlying cause of aggression will help to guide treatment.
PURPOSE OF REVIEW: Youth aggression is common and has a significant burden on individuals, families, and society. However, its treatment is often a challenge for clinicians. Thus, this review will examine the current understanding of youth aggression, conceptualize aggression as a symptom rather than its own disorder, and provide an overview of treatment strategies. RECENT FINDINGS: Youth aggression is associated with complex genetic, neurobiological, and environmental risks. Prevention strategies are of the utmost importance for at-risk families and youth. Psychosocial interventions are the first line treatment. But if not fully effective, then pharmacologic interventions-including psychostimulants, alpha-2 agonists, atomoxetine, and risperidone-have shown benefits. Other medications, such as SSRIs, can be useful in certain scenarios. It is important to conceptualize youth aggression as being a trans-diagnostic symptom in psychopathology. Determining the underlying cause of aggression will help to guide treatment.
Authors: Nancy Scotto Rosato; Christoph U Correll; Elizabeth Pappadopulos; Alanna Chait; Stephen Crystal; Peter S Jensen Journal: Pediatrics Date: 2012-05-28 Impact factor: 7.124
Authors: Shelley R Hart; Kathryn Van Eck; Elizabeth D Ballard; Rashelle J Musci; Alison Newcomer; Holly C Wilcox Journal: Psychiatry Res Date: 2017-07-20 Impact factor: 3.222
Authors: Rachel H Jacobs; Emily G Becker-Weidman; Mark A Reinecke; Neil Jordan; Susan G Silva; Paul Rohde; John S March Journal: J Clin Child Adolesc Psychol Date: 2010
Authors: L Eugene Arnold; Kenneth D Gadow; Cristan A Farmer; Robert L Findling; Oscar Bukstein; Brooke S G Molina; Nicole V Brown; Xiaobai Li; E Victoria Rundberg-Rivera; Srihari Bangalore; Kristin Buchan-Page; Elizabeth A Hurt; Robert Rice; Nora K McNamara; Michael G Aman Journal: J Child Adolesc Psychopharmacol Date: 2015-04 Impact factor: 2.576
Authors: Jianqiao Li; Margaret A Hojlo; Joseph Gonzalez-Heydrich; Catherine A Brownstein; Sampath Chennuri; Nitin Gujral; Heather L Paterson; Kent A Shefchek; Casie A Genetti; Emily L Cohn; Kara C Sewalk; Emily A Garvey; Elizabeth D Buttermore; Nickesha C Anderson; Alan H Beggs; Pankaj B Agrawal; John S Brownstein; Melissa A Haendel; Ingrid A Holm Journal: J Med Internet Res Date: 2021-03-16 Impact factor: 5.428